[{"address1": "5005 McConnell Avenue", "city": "Los Angeles", "state": "CA", "zip": "90066", "country": "United States", "phone": "310 665 2928", "fax": "310 665 2963", "website": "https://www.armatapharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.", "fullTimeEmployees": 60, "companyOfficers": [{"maxAge": 1, "name": "Dr. Deborah L. Birx M.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 554998, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David D. House", "age": 40, "title": "Senior VP of Finance & Principal Financial Officer", "yearBorn": 1984, "fiscalYear": 2024, "totalPay": 352231, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pierre  Kyme Ph.D.", "age": 46, "title": "Chief Business Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 733062, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hubbard", "title": "Vice President of Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bani  Tchekanova Ph.D.", "title": "Head of Regulatory Strategy & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.ampliphibio.com/phoenix.zhtml?c=84981&p=irol-stockquote", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.53, "open": 2.45, "dayLow": 2.45, "dayHigh": 2.6021, "regularMarketPreviousClose": 2.53, "regularMarketOpen": 2.45, "regularMarketDayLow": 2.45, "regularMarketDayHigh": 2.6021, "payoutRatio": 0.0, "beta": 1.005, "forwardPE": -1.6242037, "volume": 11335, "regularMarketVolume": 11335, "averageVolume": 247616, "averageVolume10days": 8950, "averageDailyVolume10Day": 8950, "bid": 1.91, "ask": 2.71, "bidSize": 1, "askSize": 1, "marketCap": 92385992, "fiftyTwoWeekLow": 0.9, "fiftyTwoWeekHigh": 2.96, "priceToSalesTrailing12Months": 13.451658, "fiftyDayAverage": 2.2202, "twoHundredDayAverage": 1.98635, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 227448992, "profitMargins": 0.0, "floatShares": 10840090, "sharesOutstanding": 36229800, "sharesShort": 50466, "sharesShortPriorMonth": 103565, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.69482005, "heldPercentInstitutions": 0.020299999, "shortRatio": 3.48, "shortPercentOfFloat": 0.0047999998, "impliedSharesOutstanding": 36193500, "bookValue": -1.92, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -25707000, "trailingEps": -1.07, "forwardEps": -1.57, "lastSplitFactor": "1:14", "lastSplitDate": 1557446400, "enterpriseToRevenue": 33.117, "enterpriseToEbitda": -6.711, "52WeekChange": 0.089743614, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 2.55, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 4328000, "totalCashPerShare": 0.12, "ebitda": -33893000, "totalDebt": 139467008, "quickRatio": 0.054, "currentRatio": 0.063, "totalRevenue": 6868000, "revenuePerShare": 0.19, "returnOnAssets": -0.23353, "grossProfits": -22890000, "freeCashflow": -23426376, "operatingCashflow": -31581000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -3.1553698, "financialCurrency": "USD", "symbol": "ARMP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 0.790513, "regularMarketPrice": 2.55, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 769440600000, "postMarketChangePercent": -8.235295, "postMarketPrice": 2.34, "postMarketChange": -0.21000004, "regularMarketChange": 0.02, "regularMarketDayRange": "2.45 - 2.6021", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 247616, "fiftyTwoWeekLowChange": 1.65, "fiftyTwoWeekLowChangePercent": 1.8333334, "fiftyTwoWeekRange": "0.9 - 2.96", "fiftyTwoWeekHighChange": -0.4100001, "fiftyTwoWeekHighChangePercent": -0.13851354, "fiftyTwoWeekChangePercent": 8.974361, "dividendDate": 1557446400, "earningsTimestamp": 1755028800, "earningsTimestampStart": 1755028800, "earningsTimestampEnd": 1755028800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.07, "epsForward": -1.57, "epsCurrentYear": -1.46, "priceEpsCurrentYear": -1.7465752, "corporateActions": [], "postMarketTime": 1755296011, "regularMarketTime": 1755285116, "exchange": "ASE", "messageBoardId": "finmb_84546611", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Armata Pharmaceuticals, Inc.", "longName": "Armata Pharmaceuticals, Inc.", "fiftyDayAverageChange": 0.3297999, "fiftyDayAverageChangePercent": 0.14854512, "twoHundredDayAverageChange": 0.5636499, "twoHundredDayAverageChangePercent": 0.28376162, "priceToBook": -1.328125, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Armata Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]